TherapeuticsMD TXMD
NASDAQ TXMD
$2.06 +0.03 (+1.48%)
At close: Aug 20, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Return on Sales Growth (1y) (2012 - 2026)

TherapeuticsMD (TXMD) Return on Sales Growth (1y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 0.00
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 0.00
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 0.00
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 0.00
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 0.00
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 0.00
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 0.00
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 TherapeuticsMD 23.54 Mn 14.35 Mn - 0.00

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 -1.00
Sep 30, 2024 37.00
Jun 30, 2024 0.00
Mar 31, 2024 3.00
Dec 31, 2023 1.00
Sep 30, 2023 4.00
Jun 30, 2023 -365.00
Mar 31, 2023 42.00
Dec 31, 2022 -2.00
Sep 30, 2022 -39.00
Jun 30, 2022 367.00
Mar 31, 2022 -43.00
Dec 31, 2021 5.00
Sep 30, 2021 0.00